Literature DB >> 14743366

Mutational analysis of neurotensin in familial restless legs syndrome.

Alex Desautels1, Gustavo Turecki, Lan Xiong, Daniel Rochefort, Jacques Montplaisir, Guy A Rouleau.   

Abstract

A susceptibility locus for restless legs syndrome (RLS) has been identified recently on chromosome 12q. This region contains several transcribed genes including neurotensin (NTS), which, as an important modulator of the dopaminergic transmission, represents a strong functional and positional candidate in the context of RLS. In this study, NTS was evaluated for mutational analysis. A panel of 19 individuals from 4 families supporting linkage to 12q was investigated using a combined denaturing high-performance liquid chromatography (dHPLC) and direct sequencing method. Analysis of the NTS genomic sequence revealed 2 intronic polymorphisms and 1 variant located in the 5' untranslated region (UTR). None of the observed variants co-segregated with RLS and no disease-associated polymorphisms were detected in any of the analyzed families. Based on these results, it is unlikely that NTS is the gene responsible for RLS in chromosome 12-linked families. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14743366     DOI: 10.1002/mds.10617

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  3 in total

Review 1.  Genetic aspects of restless legs syndrome.

Authors:  V Dhawan; M Ali; K R Chaudhuri
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

2.  The influence of parathyroidectomy on restless legs syndrome in patients with renal hyperparathyroidism.

Authors:  Ralph Schneider; Elias Karakas; Detlef K Bartsch; Katja Schlosser
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

3.  Reassessment of candidate gene studies for idiopathic restless legs syndrome in a large genome-wide association study dataset of European ancestry.

Authors:  Barbara Schormair; Chen Zhao; Aaro V Salminen; Konrad Oexle; Juliane Winkelmann
Journal:  Sleep       Date:  2022-08-11       Impact factor: 6.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.